Healthcare Nanotechnology Market to Show Higher CAGR Above 12% Till 2024 - PowerPoint PPT Presentation

About This Presentation
Title:

Healthcare Nanotechnology Market to Show Higher CAGR Above 12% Till 2024

Description:

Increasing demand of nanotechnology owing to the development programs funded by both government and private sectors organization for cardiovascular and neurology based diseases is also expected to drive the market for healthcare nanotechnology. – PowerPoint PPT presentation

Number of Views:28

less

Transcript and Presenter's Notes

Title: Healthcare Nanotechnology Market to Show Higher CAGR Above 12% Till 2024


1
Your Catalyst To a Lucrative Business Healthcare
Nanotechnology Market Share, Size, Analysis,
Growth, Strategies, Trends and Forecasts to 2024
Hexa Research
" Healthcare Nanotechnology Market to Show a CAGR
above 12 till 2024."
The global Healthcare Nanotechnology Market is
anticipated to grow at a CAGR surpassing 12 from
2016 to 2024 (forecast period). This market is
primarily driven by technological advancements
innovations in nanotechnology. Nanotechnology in
healthcare aims at curing molecular
submicroscopic part s by monitoring repairing,
and by reconstructing them. This industry is
propelled by development initiatives that are
funded by government private organizations
that focus on neurological cardiovascular
ailments. Focus on enhancing drug efficiency
also has a favorable impact on market demand.
Nanotechnology is expected to gain importance in
the areas of disease prevention, diagnosis, and
therapy. The global healthcare nanotechnology
market is segmented on the basis of applications,
end users, and reg ions. On the basis of
applications, the industry is categorized into
clinical cardiology, drug delivery systems,
clinical neurology, molecular diagnostics,
clinical oncology, and anti-inflammatory
anti-infective applications. The other
applications are kidney andophthalmology, dental,
hematology, and orthopedic. Clinical oncology is
a rapidly growing segment due to the efficacy of
nano particles to fight against cancerous tissues
tumors. Browse Details of Report
_at_ https//www.hexaresearch.com/research-report/hea
lthcare-nanotechnology-industry
2
Your Catalyst To a Lucrative Business High
incidence of cardiovascular anomalies can augment
the cardiovascular segment over the forecast
period. The market for nanotechnology
applications in cardiology holds high growth
potential in most developing underdeveloped
economies. The anti-infective segment is
projected to expand considerably because of
rising prevalence of air-borne diseases, bird
flu, and swine flu. Based on end users, the
market is trifurcated into ambulatories,
clinics, and hospitals. The hospitals segment
may expand substantially owing to rising cases of
chronic ailments and high awareness about
disease prevention. A number of large and medium
sized hospitals have begun adopting
nanotechnology. Unlike small hospitals that have
limited resources, the large ones can adopt newer
technologies because of favorable budgetary
conditions. Geographically, the global industry
is divided into Asia Pacific, North America,
Europe, and Rest of the World. North America
held the highest share in terms of revenue in
2014. Factors, such as high investments and
sophisticated technologies can fuel this region
in the forthcoming years. Ongoing industry trends
suggest that Asia Pacific may register a high
rate of growth at the same time. Key regional
drivers are surging disposable incomes,
outsourcing of healthcare services, and growing
population. Prominent companies operating in the
worldwide healthcare nanotechnology market are
Celgene Corporation, CombiMatrix Corporation,
Johnson Johnson, Abbott Laboratories, and Teva
Pharmaceuticals Industries Ltd. Characterized by
stiff competition, the industry witnesses
frequent business ventures and regional expansion
initiatives. Researchers scientists are
trying to develop nanosensors that can detect the
occur rence of heart attacks (myocardial
infarction). This could not only save lives but
also money. Such a technology uses miniature
blood stream nanosensors chips that can sense
the onset of a heart attack. An individual with
the help of this tiny chip can receive a warning
on some wireless device or smartphone to
immediately seek medical help. The updated
version of this chip measures only ninety microns
(a size way lesser than a sand grain). This
combination of a smartphone and a nanosensor may
even help detect certain types of cancers and
autoimmune diseases. These sensors are mostly
used in animals for glucose detection. Browse
Related Category Market Reports _at_
https//www.hexaresearch.com/research-category/bio
technology-industry
3
  • Your Catalyst To a Lucrative Business
  • Table of Content of Healthcare Nanotechnology
    Market Chapter 1. Executive Summary
  • 1.1. Nanotechnology Healthcare - Industry
    Summary Critical Success Factors (CSFs)
  • Chapter 2. Nanotechnology Healthcare Industry
    Outlook
  • Market Segmentation
  • Market Size and Growth Prospects
  • Nanotechnology Healthcare Market Dynamics
  • Market Driver Analysis
  • Growing incidences of chronic severe diseases
  • Technological innovation in medical application
    of nanotechnology
  • Growing geriatric population base
  • Key Opportunities Prioritized
  • Industry Analysis - Porter's
  • Nanotechnology Healthcare market PESTEL Analysis,
    2013
  • Chapter 3. Nanotechnology Healthcare Application
    Outlook
  • Drug Delivery System
  • Global revenue by region, 2016 - 2024 (USD
    Million)

4
  • Your Catalyst To a Lucrative Business
  • 4.2.1. Market revenue by application, 2016 -
    2024 (USD Million)
  • Asia Pacific
  • Market revenue by application, 2016 - 2024 (USD
    Million)
  • RoW
  • Market revenue by application, 2016 - 2024 (USD
    Million)
  • Chapter 5 Competitive Landscape
  • Abbott Laboratories.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • CombiMatrix Corporation
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Celgene Corporation

5
  • Your Catalyst To a Lucrative Business
  • 5.6.4 Strategic Initiatives
  • Merck Company Inc.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Nanosphere Inc.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Pfizer Inc.
  • Company Overview
  • Financial Performance
  • Product Benchmarking
  • Strategic Initiatives
  • Sigma-Tau Pharmaseuticals Inc.
  • Company Overview

6
Your Catalyst To a Lucrative Business About
Us Hexa Research is a market research and
consulting organization, offering industry
reports, custom research and consulting services
to a host of key industries across the globe. We
offer comprehensive business intelligence in the
form of industry reports which help our clients
obtain clarity about their business environment
and enable them to undertake strategic growth
initiatives. Contact Us Ryan Shaw Hexa
Research Felton Office Plaza 6265 Highway
9 Felton, California 95018 United States Phone
1-800-489-3075 Email sales_at_hexaresearch.com Webs
ite - http//www.hexaresearch.com/ Visit our
Blog https//hexaresearchinc.wordpress.com/
Write a Comment
User Comments (0)
About PowerShow.com